Previous Article | Next Article ![]()
Journal of Clinical Microbiology, February 2006, p. 622-624, Vol. 44, No. 2
0095-1137/06/$08.00+0 doi:10.1128/JCM.44.2.622-624.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Departments of Pathology & Laboratory Medicine,1 Microbiology & Infectious Diseases,2 Medicine, University of Calgary,3 Division of Microbiology, Calgary Laboratory Services, Calgary, Alberta, Canada4
Received 15 November 2005/ Returned for modification 3 December 2005/ Accepted 5 December 2005
|
|
|---|
|
|
|---|
Assay development and evaluation were performed at Calgary Laboratory Services, an integrated laboratory serving an urban population of 1.25 million people. Peripheral blood specimens for malaria diagnosis are routinely processed and analyzed according to CLSI standards (1, 15). Positive samples are further retained at 80°C for conventional species-specific PCR confirmation by a reference laboratory (Toronto General Hospital, Toronto, Canada). In the present study, 28 frozen nonduplicate microscopy-positive peripheral blood specimens and 50 randomly selected microscopy-negative specimens collected over a 25-month period from May 2001 to June 2003 were tested in a blind fashion. Template DNA was purified using QIAamp DNA blood mini kits (QIAGEN Inc., Alameda, CA). Two sets of oligonucleotide primers were designed to specifically amplify, respectively, a 120-bp region of the cytochrome c oxidase subunit 1 (cox1) mitochondrial gene unique to P. falciparum (forward primer, 5'-TTACATCAGGAATGTTATTGC-3', and reverse primer, 5'-ATATTGGATCTCCTGCAAAT-3') and a 105-bp conserved region of the 18S rRNA gene found in all Plasmodium species (forward primer, 5'-TAGTGTGTATCAATCGAGTT-3', and reverse primer, 5'-CTCTCCGGAATCGAACT-3'). Molecular beacon probes (5'-FAM-CTGGCCCTGGAGGAGTATTAATGTTATTATCGGC CAG-BHQ1-3' and 5'-FAM-CTCGCGCTTTTGATGTTAGGGTATTGGGCGAG-BHQ1-3') (where FAM is 6-carboxy- fluorescein, BHQ1 is black hole quencher-1, and underlined bases form the molecular beacon probe stem) were designed to hybridize to the aforementioned cox1 and 18S rRNA amplicons, respectively. Real-time PCR was performed on the Stratagene Mx4000 system (Stratagene Inc., La Jolla, CA). Singleplex reactions were performed in 50-µl final volumes based on a previously described protocol (5), except for concentrations of MgCl2 and the beacon probe of 6 mM and 0.4 µM, respectively. Thermocycling parameters were as previously described (5), except for an annealing temperature of 50°C and no final extension stage. Fluorescence data were measured during the annealing stage of amplification. The presence of a specific amplicon was established when the fluorescence intensity of the probe exceeded background fluorescence as defined by no-template controls included in each run. Diagnosis of non-P. falciparum malaria was based on a positive Plasmodium genus-specific PCR test and negative P. falciparum PCR test. Analytical sensitivity was determined by testing serial 10-fold dilutions of sequential peripheral blood specimens from patients with acute malaria and known parasitemia.
A total of 78 specimens were tested by real-time PCR, of which 11 were positive for P. falciparum and 16 for non-P. falciparum spp. There were no patients with mixed infections as determined by microscopy or conventional PCR. All 50 microscopy-negative specimens were negative by both real-time and conventional PCR. Complete concordance was noted apart from two discrepancies. One patient was presumed to have P. falciparum malaria on the basis of microscopy but had negative conventional and real-time PCR results; after reexamination of the blood films, no malarial parasites were observed. Additionally, one patient presumed to have P. ovale malaria on the basis of microscopy was found to be positive for P. falciparum by conventional and real-time PCR (Table 1). There was no significant amplification of no-template controls. Figure 1 shows representative fluorescence-versus-cycle curves for the 18S rRNA gene PCR assay. The sensitivity limit of our P. falciparum-specific real-time PCR assay was determined to be 0.004 parasite/µl blood, while that for the genus-specific assay was at least 0.16 parasite/µl, depending on the species tested.
|
View this table: [in a new window] |
TABLE 1. Comparison of microscopy, conventional PCR, and real-time PCR for malaria diagnosis
|
![]() View larger version (21K): [in a new window] |
FIG. 1. Representative singleplex 18S rRNA gene (Plasmodium genus-specific) PCR fluorescence-versus-cycle curves for three clinical samples with various parasitemias as determined by microscopy.
|
1 parasite/µl (8, 13, 14). Notwithstanding the robustness of conventional PCR methods, these assays have several limitations and are only semiquantitative in nature. The recent emergence of real-time PCR technology has overcome these pitfalls, while allowing for continuous monitoring of the PCR. Our experience demonstrates the power, speed, and ease of real-time PCR for malaria diagnosis. With a total assay time of 2 h, our assays are sufficiently robust for routine clinical use. To date, no other molecular beacon probe-based real-time PCR assays for malaria diagnosis have been reported prior to ours, although other investigators have described their experience with TaqMan probes (9, 10, 17, 18) and SYBR green dye (4, 6, 12). The Plasmodium 18S (small-subunit) rRNA gene has served as the prototypic target for genus-based malaria PCR assays (2-4, 6, 7, 9-12, 14, 16, 18), although the cox1 gene has not previously been used for P. falciparum malaria identification. The main limitations of our method are the need for two separate PCRs, the lack of an internal control, and no specimens with P. malariae. While combining these two assays would enhance the attractiveness of our approach, multiplexing the cox1 and 18S rRNA assays results in lower analytic sensitivity, especially if fluorophores other than FAM are used (unpublished observations). While recommended to ascertain adequate sample preparation and PCR amplification, we found that inclusion of an internal control (beta-globin gene) resulted in greatly decreased assay sensitivity (data not shown). While not intended to completely replace conventional microscopy, our assays would find the greatest utility in helping to rule out the presence of P. falciparum in patients with low-level parasitemia, as well as confirming the diagnosis of malaria in clinically compatible cases with negative microscopy results. While mixed infections cannot be diagnosed with our set of assays, this is of lesser immediate clinical importance, especially if P. falciparum can be ruled out, although this may be remedied by future enhancements to real-time PCR methodologies and to our existing assay. Based on our observations (data not shown), probe fluorescence appears to correlate well with parasitemia, suggesting that real-time PCR may become the new "gold standard" for monitoring therapeutic responses to antimalarial agents. Despite the very high sensitivity of real-time PCR, repeat testing is indicated, based on clinical suspicion, if initial results are negative. At this time, however, the costs associated with routine implementation of molecular diagnostics for malaria diagnosis would be too prohibitive for countries where malaria is endemic.
(This study was presented in part at the 44th Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, D.C., 30 October 2004 [abstract P-426]).
We thank Kevin Kain, Toronto General Hospital, for reference PCR testing services.
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»